Merve Gürler, Mustafa Kürsat Gōkcan, Seher Yüksel, Zeynep Ceren Karahan
{"title":"Association between human herpesviruses and head and neck squamous cell carcinoma: a molecular perspective.","authors":"Merve Gürler, Mustafa Kürsat Gōkcan, Seher Yüksel, Zeynep Ceren Karahan","doi":"10.5144/0256-4947.2025.104","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Head and neck cancer (HNC) is the seventh most common malignant tumor. Herpesviruses are a significant risk factor in the multifactorial pathogenesis of HNC.</p><p><strong>Objectives: </strong>This study aimed to investigate the association between herpesviruses and the development of head and neck squamous cell carcinoma (HN-SCC).</p><p><strong>Design: </strong>Experimental study.</p><p><strong>Setting: </strong>A university hospital in Turkey.</p><p><strong>Patients and methods: </strong>Pathological archive tissue samples of 500 patients were included in the study. These samples were categorized into two groups: those diagnosed with HN-SCC (n=300, malignant group [MG]) and those diagnosed with benign head and neck lesions (n=200, benign group [BG]). The presence of herpesvirus in samples was detected using polymerase chain reaction.</p><p><strong>Main outcome measures: </strong>Association of herpesviruses in the development of head and neck cancer.</p><p><strong>Sample size: </strong>500 patients.</p><p><strong>Results: </strong>HHV-1, -2, -7, and -8 were not detected in any samples. In the malignant group (MG), EBV-DNA was detected in 1 patient (0.3%) and HHV-6 DNA in 2 patients (0.6%), while in the benign group (BG), VZV-DNA was detected in 1 patient (0.5%), EBV-DNA in 3 patients (1.5%), CMV-DNA in 5 patients (2.5%), and HHV-6 DNA in 3 patients (1.5%). While no significant difference was found between the groups for VZV, EBV, and HHV-6, a statistically significant difference was found in favor of the benign group for CMV.</p><p><strong>Conclusion: </strong>Although herpesvirus seroprevalence is relatively high in the population, the lack of viral genome in tissue samples indicates that other factors might be prominent in developing HN-SCC.</p><p><strong>Limitation: </strong>The storage conditions of the sample used (paraffinized sample) may have negatively affected the detection frequency of HHVs.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"45 2","pages":"104-111"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11973434/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Saudi medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5144/0256-4947.2025.104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Head and neck cancer (HNC) is the seventh most common malignant tumor. Herpesviruses are a significant risk factor in the multifactorial pathogenesis of HNC.
Objectives: This study aimed to investigate the association between herpesviruses and the development of head and neck squamous cell carcinoma (HN-SCC).
Design: Experimental study.
Setting: A university hospital in Turkey.
Patients and methods: Pathological archive tissue samples of 500 patients were included in the study. These samples were categorized into two groups: those diagnosed with HN-SCC (n=300, malignant group [MG]) and those diagnosed with benign head and neck lesions (n=200, benign group [BG]). The presence of herpesvirus in samples was detected using polymerase chain reaction.
Main outcome measures: Association of herpesviruses in the development of head and neck cancer.
Sample size: 500 patients.
Results: HHV-1, -2, -7, and -8 were not detected in any samples. In the malignant group (MG), EBV-DNA was detected in 1 patient (0.3%) and HHV-6 DNA in 2 patients (0.6%), while in the benign group (BG), VZV-DNA was detected in 1 patient (0.5%), EBV-DNA in 3 patients (1.5%), CMV-DNA in 5 patients (2.5%), and HHV-6 DNA in 3 patients (1.5%). While no significant difference was found between the groups for VZV, EBV, and HHV-6, a statistically significant difference was found in favor of the benign group for CMV.
Conclusion: Although herpesvirus seroprevalence is relatively high in the population, the lack of viral genome in tissue samples indicates that other factors might be prominent in developing HN-SCC.
Limitation: The storage conditions of the sample used (paraffinized sample) may have negatively affected the detection frequency of HHVs.